ArticleOncoTargets and therapy2021

Sustained Clinical Benefit of Pyrotinib Combined with Capecitabine Rescue Therapy After Trastuzumab Resistance in HER2-Positive Advanced Gastric Cancer: A Case Report.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.